Combining diffusion and perfusion differentiates tumor from bevacizumab-related imaging abnormality

ResourcesPatient ResourcesTestimonialsCombining diffusion and perfusion differentiates tumor from bevacizumab-related imaging abnormality

Combining diffusion and perfusion differentiates tumor from bevacizumab-related imaging abnormality

  • Date: December 30, 2014
  • Type:
  • Size:

Download